We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Cost effectiveness of paliperidone palmitate for the treatment of schizophrenia in Germany.
- Authors
Zeidler, Jan; Mahlich, Jörg; Greiner, Wolfgang; Heres, Stephan
- Abstract
Treatment with antipsychotic medication is an important element of relapse prevention in the management of schizophrenia, and can reduce inpatient stays. Recently, the long-acting atypical antipsychotic paliperidone long-acting injectable (PLAI), a once-monthly LAI antipsychotic, was approved for treatment of schizophrenia in Germany.
- Publication
Applied health economics and health policy, 2013, Vol 11, Issue 5, p509
- ISSN
1179-1896
- Publication type
Journal Article
- DOI
10.1007/s40258-013-0050-0